Literature DB >> 33788940

A Highly Automated Mobile Laboratory for On-site Molecular Diagnostics in the COVID-19 Pandemic.

Wanli Xing1,2,3, Jiadao Wang4, Chao Zhao5, Han Wang1, Liang Bai3, Liangbin Pan2,3, Hang Li2, Huili Wang1, Zhi Zhang2, Ying Lu1, Xiang Chen3, Sisi Shan6, Dong Wang2, Yifei Pan2, Ding Weng4, Xinying Zhou3, Rudan Huang2, Jianxing He7, Ronghua Jin8, Weimin Li9, Hong Shang10, Nanshan Zhong11, Jing Cheng1,2.   

Abstract

BACKGROUND: Infectious disease outbreaks such as the COVID-19 (coronavirus disease 2019) pandemic call for rapid response and complete screening of the suspected community population to identify potential carriers of pathogens. Central laboratories rely on time-consuming sample collection methods that are rarely available in resource-limited settings.
METHODS: We present a highly automated and fully integrated mobile laboratory for fast deployment in response to infectious disease outbreaks. The mobile laboratory was equipped with a 6-axis robot arm for automated oropharyngeal swab specimen collection; virus in the collected specimen was inactivated rapidly using an infrared heating module. Nucleic acid extraction and nested isothermal amplification were performed by a "sample in, answer out" laboratory-on-a-chip system, and the result was automatically reported by the onboard information platform. Each module was evaluated using pseudovirus or clinical samples.
RESULTS: The mobile laboratory was stand-alone and self-sustaining and capable of on-site specimen collection, inactivation, analysis, and reporting. The automated sampling robot arm achieved sampling efficiency comparable to manual collection. The collected samples were inactivated in as short as 12 min with efficiency comparable to a water bath without damage to nucleic acid integrity. The limit of detection of the integrated microfluidic nucleic acid analyzer reached 150 copies/mL within 45 min. Clinical evaluation of the onboard microfluidic nucleic acid analyzer demonstrated good consistency with reverse transcription quantitative PCR with a κ coefficient of 0.979.
CONCLUSIONS: The mobile laboratory provides a promising solution for fast deployment of medical diagnostic resources at critical junctions of infectious disease outbreaks and facilitates local containment of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) transmission. © American Association for Clinical Chemistry 2021. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33788940     DOI: 10.1093/clinchem/hvab027

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

Review 1.  SARS-CoV-2 Diagnostics Based on Nucleic Acids Amplification: From Fundamental Concepts to Applications and Beyond.

Authors:  João M Vindeirinho; Eva Pinho; Nuno F Azevedo; Carina Almeida
Journal:  Front Cell Infect Microbiol       Date:  2022-03-23       Impact factor: 5.293

2.  Lab-in-a-van: Rapid SARS-CoV-2 testing response with a mobile laboratory.

Authors:  Susan A Ballard; Maryza Graham; Debra David; Tuyet Hoang; Angela Donald; Michelle Sait; Nicole Isles; Amelia Matlock; Sarah Yallop; Mark Bek; Benjamin P Howden; Timothy P Stinear
Journal:  EBioMedicine       Date:  2022-04-08       Impact factor: 11.205

Review 3.  Microfluidics-based strategies for molecular diagnostics of infectious diseases.

Authors:  Xin Wang; Xian-Zhe Hong; Yi-Wei Li; Ying Li; Jie Wang; Peng Chen; Bi-Feng Liu
Journal:  Mil Med Res       Date:  2022-03-18

4.  Mobile primary healthcare for post-COVID patients in rural areas: a proof-of-concept study.

Authors:  Andreas Stallmach; Katrin Katzer; Bianca Besteher; Kathrin Finke; Benjamin Giszas; Yvonne Gremme; Rami Abou Hamdan; Katja Lehmann-Pohl; Maximilian Legen; Jan Christoph Lewejohann; Marlene Machnik; Majd Moshmosh Alsabbagh; Luisa Nardini; Christian Puta; Zoe Stallmach; Philipp A Reuken
Journal:  Infection       Date:  2022-07-13       Impact factor: 7.455

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.